A major current limitation, however, remains the rapid dispersion and limited intralesional retention of free exosomes following injection, which may restrict their therapeutic bioavailability
In the long term, and this is the larger play, it normalises human enhancement as a mass consumer category
Having been diagnosed with acne rosacea at 30 years old (some 25 years ago, yikes!) and researching this skin disorder, I knew I was in for a long haul of trying to control this chronic condition that was bestowed on me
The Bottom Line The FDA 503A Bulks List is a regulatory pathway for traditional compounding from certain active pharmaceutical ingredients
It directly affects what kind of results you can expect, how quickly you will see them, and what trade-offs you will face